Company intelligence / Profile preview

PharmaSophia

Oakwood Village, Ohio, United States

Ownership: Private
Development stage: Other

Overview

PharmaSophia, LLC is a specialty pharmaceutical joint venture formed by Nava Pharma, LLC and Oakwood Laboratories, LLC. The company is focused on the development of hard-to-develop generic and quasi-generic, sustained-release injectable drugs. PharmaSophia leverages Oakwood's advanced microsphere-based drug delivery technology (ChroniJect) and Nava's research capabilities, subcontracting development work to Amneal Pharmaceuticals. Its lead product is a sustained-release injectable formulation of risperidone, which is commercialized in partnership with Amneal.

Therapeutic areas: Psychiatry
Modalities: Small molecule
Industry: Pharma

Partnerships

Nava PharmaOakwood LaboratoriesAmneal Pharmaceuticals

Beyond the preview

Go deeper on PharmaSophia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaSophia.

Explore the full profile